Global Cancer Monoclonal Antibody Partnering, Deal Trends and Financial Agreements During 2010-2017 Analyzed by Active Players
Report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies.
View full press release